Dexamethasone suppression test and selection of antidepressant medications

John F. Greden, Ziad Kronfol, Robert Gardner, Michael Feinberg, Sunil Mukhopadhyay, A. Ariav Albala, Bernard J. Carroll

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Endogenous depressives with abnormal dexamethasone suppression tests (DSTs) respond better to somatic antidepressant treatments than those with normal DSTs. Whether the DST also aids in the selection of specific antidepressants has not been determined. A pilot report suggested that patients with abnormal DSTs might be noradrenaline-deficient and respond preferentially to imipramine or desipramine, whereas those with normal DSTs might be serotonin-deficient and respond best to amitriptyline or clomipramine. Attempting to replicate this observation, we studied 26 patients diagnosed with Research Diagnostic Criteria as major depressive disorder, endogenous subtype, and with DSM-III as having melancholia. All were drug-free during baseline evaluation. All had abnormal DST results, with post-dexamethasone plasma cortisol levels exceeding 5 μg/dl. We treated subjects with either imipramine or amitriptyline and compared clinical response with weekly Hamilton Depression Rating Scales, completed by raters blind to both DST results and the research question. Therapeutic plasma levels were documented. We found no significant differences in treatment response between the subgroups. Twenty of the 26 subjects did well. The imipramine-treated group failed to have either earlier response or better final outcome. These data fail to replicate suggestions that DST results assist in the selection of either imipramine or amitriptyline.

Original languageEnglish
Pages (from-to)389-396
Number of pages8
JournalJournal of Affective Disorders
Volume3
Issue number4
DOIs
Publication statusPublished - 1981
Externally publishedYes

Fingerprint

Dexamethasone
Antidepressive Agents
Imipramine
Amitriptyline
Clomipramine
Desipramine
Major Depressive Disorder
Depressive Disorder
Research
Diagnostic and Statistical Manual of Mental Disorders
Hydrocortisone
Serotonin
Norepinephrine
Therapeutics
Depression
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Behavioral Neuroscience
  • Biological Psychiatry
  • Neurology
  • Psychology(all)

Cite this

Greden, J. F., Kronfol, Z., Gardner, R., Feinberg, M., Mukhopadhyay, S., Albala, A. A., & Carroll, B. J. (1981). Dexamethasone suppression test and selection of antidepressant medications. Journal of Affective Disorders, 3(4), 389-396. https://doi.org/10.1016/0165-0327(81)90007-0

Dexamethasone suppression test and selection of antidepressant medications. / Greden, John F.; Kronfol, Ziad; Gardner, Robert; Feinberg, Michael; Mukhopadhyay, Sunil; Albala, A. Ariav; Carroll, Bernard J.

In: Journal of Affective Disorders, Vol. 3, No. 4, 1981, p. 389-396.

Research output: Contribution to journalArticle

Greden, JF, Kronfol, Z, Gardner, R, Feinberg, M, Mukhopadhyay, S, Albala, AA & Carroll, BJ 1981, 'Dexamethasone suppression test and selection of antidepressant medications', Journal of Affective Disorders, vol. 3, no. 4, pp. 389-396. https://doi.org/10.1016/0165-0327(81)90007-0
Greden, John F. ; Kronfol, Ziad ; Gardner, Robert ; Feinberg, Michael ; Mukhopadhyay, Sunil ; Albala, A. Ariav ; Carroll, Bernard J. / Dexamethasone suppression test and selection of antidepressant medications. In: Journal of Affective Disorders. 1981 ; Vol. 3, No. 4. pp. 389-396.
@article{25501cc3112843f59152e5676988fbb0,
title = "Dexamethasone suppression test and selection of antidepressant medications",
abstract = "Endogenous depressives with abnormal dexamethasone suppression tests (DSTs) respond better to somatic antidepressant treatments than those with normal DSTs. Whether the DST also aids in the selection of specific antidepressants has not been determined. A pilot report suggested that patients with abnormal DSTs might be noradrenaline-deficient and respond preferentially to imipramine or desipramine, whereas those with normal DSTs might be serotonin-deficient and respond best to amitriptyline or clomipramine. Attempting to replicate this observation, we studied 26 patients diagnosed with Research Diagnostic Criteria as major depressive disorder, endogenous subtype, and with DSM-III as having melancholia. All were drug-free during baseline evaluation. All had abnormal DST results, with post-dexamethasone plasma cortisol levels exceeding 5 μg/dl. We treated subjects with either imipramine or amitriptyline and compared clinical response with weekly Hamilton Depression Rating Scales, completed by raters blind to both DST results and the research question. Therapeutic plasma levels were documented. We found no significant differences in treatment response between the subgroups. Twenty of the 26 subjects did well. The imipramine-treated group failed to have either earlier response or better final outcome. These data fail to replicate suggestions that DST results assist in the selection of either imipramine or amitriptyline.",
author = "Greden, {John F.} and Ziad Kronfol and Robert Gardner and Michael Feinberg and Sunil Mukhopadhyay and Albala, {A. Ariav} and Carroll, {Bernard J.}",
year = "1981",
doi = "10.1016/0165-0327(81)90007-0",
language = "English",
volume = "3",
pages = "389--396",
journal = "Journal of Affective Disorders",
issn = "0165-0327",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Dexamethasone suppression test and selection of antidepressant medications

AU - Greden, John F.

AU - Kronfol, Ziad

AU - Gardner, Robert

AU - Feinberg, Michael

AU - Mukhopadhyay, Sunil

AU - Albala, A. Ariav

AU - Carroll, Bernard J.

PY - 1981

Y1 - 1981

N2 - Endogenous depressives with abnormal dexamethasone suppression tests (DSTs) respond better to somatic antidepressant treatments than those with normal DSTs. Whether the DST also aids in the selection of specific antidepressants has not been determined. A pilot report suggested that patients with abnormal DSTs might be noradrenaline-deficient and respond preferentially to imipramine or desipramine, whereas those with normal DSTs might be serotonin-deficient and respond best to amitriptyline or clomipramine. Attempting to replicate this observation, we studied 26 patients diagnosed with Research Diagnostic Criteria as major depressive disorder, endogenous subtype, and with DSM-III as having melancholia. All were drug-free during baseline evaluation. All had abnormal DST results, with post-dexamethasone plasma cortisol levels exceeding 5 μg/dl. We treated subjects with either imipramine or amitriptyline and compared clinical response with weekly Hamilton Depression Rating Scales, completed by raters blind to both DST results and the research question. Therapeutic plasma levels were documented. We found no significant differences in treatment response between the subgroups. Twenty of the 26 subjects did well. The imipramine-treated group failed to have either earlier response or better final outcome. These data fail to replicate suggestions that DST results assist in the selection of either imipramine or amitriptyline.

AB - Endogenous depressives with abnormal dexamethasone suppression tests (DSTs) respond better to somatic antidepressant treatments than those with normal DSTs. Whether the DST also aids in the selection of specific antidepressants has not been determined. A pilot report suggested that patients with abnormal DSTs might be noradrenaline-deficient and respond preferentially to imipramine or desipramine, whereas those with normal DSTs might be serotonin-deficient and respond best to amitriptyline or clomipramine. Attempting to replicate this observation, we studied 26 patients diagnosed with Research Diagnostic Criteria as major depressive disorder, endogenous subtype, and with DSM-III as having melancholia. All were drug-free during baseline evaluation. All had abnormal DST results, with post-dexamethasone plasma cortisol levels exceeding 5 μg/dl. We treated subjects with either imipramine or amitriptyline and compared clinical response with weekly Hamilton Depression Rating Scales, completed by raters blind to both DST results and the research question. Therapeutic plasma levels were documented. We found no significant differences in treatment response between the subgroups. Twenty of the 26 subjects did well. The imipramine-treated group failed to have either earlier response or better final outcome. These data fail to replicate suggestions that DST results assist in the selection of either imipramine or amitriptyline.

UR - http://www.scopus.com/inward/record.url?scp=0019808366&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019808366&partnerID=8YFLogxK

U2 - 10.1016/0165-0327(81)90007-0

DO - 10.1016/0165-0327(81)90007-0

M3 - Article

VL - 3

SP - 389

EP - 396

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

SN - 0165-0327

IS - 4

ER -